Literature DB >> 21873070

SAR studies of acidic dual γ-secretase/PPARγ modulators.

Martina Hieke1, Julia Ness, Ramona Steri, Christine Greiner, Oliver Werz, Manfred Schubert-Zsilavecz, Sascha Weggen, Heiko Zettl.   

Abstract

A novel set of dual γ-secretase/PPARγ modulators characterized by a 2-benzyl hexanoic acid scaffold is presented. Synthetic efforts were focused on the variation of the substitution pattern of the central benzene. Finally, we obtained a new class of 2,5-disubstituted 2-benzylidene hexanoic acid derivatives, which act as dual γ-secretase/PPARγ modulators in the low micromolar range. We have explored broad SAR and successfully improved the dual pharmacological activity and the selectivity profile against potential off-targets such as NOTCH and COX. Compound 17 showed an IC(50) Aβ42=2.4 μM and an EC(50) PPARγ=7.2 μM and could be a valuable tool to further evaluate the concept of dual γ-secretase/PPARγ modulators in animal models of Alzheimer's disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873070     DOI: 10.1016/j.bmc.2011.08.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.

Authors:  Maximilian Pohland; Stephanie Hagl; Maren Pellowska; Mario Wurglics; Manfred Schubert-Zsilavecz; Gunter P Eckert
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

2.  MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.

Authors:  Maximilian Pohland; Maren Pellowska; Heike Asseburg; Stephanie Hagl; Martina Reutzel; Aljoscha Joppe; Dirk Berressem; Schamim H Eckert; Mario Wurglics; Manfred Schubert-Zsilavecz; Gunter P Eckert
Journal:  Alzheimers Res Ther       Date:  2018-02-13       Impact factor: 6.982

3.  Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.

Authors:  Teresa Kaserer; Veronika Temml; Zsofia Kutil; Tomas Vanek; Premysl Landa; Daniela Schuster
Journal:  Eur J Med Chem       Date:  2015-04-08       Impact factor: 6.514

4.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

5.  Identification and structural insight of an effective PPARγ modulator with improved therapeutic index for anti-diabetic drug discovery.

Authors:  Haowen Jiang; X Edward Zhou; Jingjing Shi; Zhi Zhou; Guanguan Zhao; Xinwen Zhang; Yili Sun; Kelly Suino-Powell; Lei Ma; Hui Gao; Xiyong Yu; Jia Li; Jingya Li; Karsten Melcher; H Eric Xu; Wei Yi
Journal:  Chem Sci       Date:  2020-01-21       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.